drugset / Trial / NCT00158210

Rivastigmine For Methamphetamine Dependent Individuals

NCT00158210

RandomizedParallel-groupDouble-blindTreatment

Summary

Methamphetamine abuse has been steadily increasing over the past decade. Rivastigmine is a medication that may be helpful in treating methamphetamine dependence. The purpose of this study is to evaluate the effectiveness of rivastigmine in treating methamphetamine dependent individuals.

Timeline

Start
2006-05
Primary completion
2007-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Rivastigmine Small molecule